LSM2 and central nervous system cancer: Specifically, LSM2 depletion resulted in the upregulation of extracellular matrix (ECM) genes like FN1 and COL1A1, which could disrupt tumour cell-ECM interactions and potentially diminish the invasive phenotypes of glioma cells.